| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10308388 | Schizophrenia Research | 2005 | 16 Pages |
Abstract
These results provide support for the hypothesis that the adjunctive administration of dopamine agonist can improve cognitive in individuals with schizophrenia taking typical antipsychotics. The results are discussed in terms of their implications for understanding the nature of working memory deficits in schizophrenia, and potential future avenues for cognitive enhancement in this illness.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Deanna M. Barch, Cameron S. Carter,